Glaukos (GKOS) EBIAT (2016 - 2025)
Glaukos (GKOS) has disclosed EBIAT for 12 consecutive years, with -$133.7 million as the latest value for Q4 2025.
- Quarterly EBIAT fell 298.05% to -$133.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$187.7 million through Dec 2025, down 28.23% year-over-year, with the annual reading at -$187.7 million for FY2025, 28.23% down from the prior year.
- EBIAT for Q4 2025 was -$133.7 million at Glaukos, down from -$16.2 million in the prior quarter.
- The five-year high for EBIAT was $6.2 million in Q3 2021, with the low at -$133.7 million in Q4 2025.
- Average EBIAT over 5 years is -$30.9 million, with a median of -$29.0 million recorded in 2022.
- The sharpest move saw EBIAT soared 139.56% in 2021, then plummeted 743.97% in 2023.
- Over 5 years, EBIAT stood at -$21.9 million in 2021, then crashed by 43.84% to -$31.5 million in 2022, then fell by 16.91% to -$36.8 million in 2023, then grew by 8.7% to -$33.6 million in 2024, then tumbled by 298.05% to -$133.7 million in 2025.
- According to Business Quant data, EBIAT over the past three periods came in at -$133.7 million, -$16.2 million, and -$19.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.